Additionally, TDP-43 could disrupt ER-mitochondria associations by reducing the binding of VAPB-PTPIP51, which contribute to the pathological features of ALS/FTD (Stoica et al., 2014). Here, RMDN3 is linked to amyotrophic lateral sclerosis.